Literature DB >> 8940071

Characterization of the mouse epidermal growth factor promoter and 5'-flanking region. Role for an atypical TATA sequence.

S E Fenton1, N S Groce, D C Lee.   

Abstract

As a step toward delineating mechanisms that regulate its activity, we have characterized the mouse epidermal growth factor (EGF) promoter. Primer extension and S1 nuclease analyses identified prominent (+1/+2) and minor (+28) transcription start sites, with the dominant +1/+2 site located 33 bases downstream from a TTTAAA sequence. A restriction fragment that spanned these start sites and contained 390 base pairs of 5'-flanking sequence directed transcription from the +1/+2 site in vitro in the presence of HeLa cell nuclear extracts. Additionally, it promoted expression of a coupled luciferase reporter gene in transfected cell lines. The inclusion of additional 5'-flanking sequence either stimulated or inhibited luciferase expression depending on the cell line. Approximately 2 kilobases of EGF 5'-flanking sequence was determined and found to contain several motifs with partial homology to steroid hormone response elements. Despite this fact and evidence that EGF expression might be regulated by androgens in vivo, EGF promoter-luciferase constructs were not steroid-responsive in cells cotransfected with steroid receptor expression vectors. An oligonucleotide containing the aforementioned TTTAAA sequence specifically bound TATA-binding protein and TFIIA in gel shift assays, and an EGF promoter-luciferase construct in which the core TA dinucleotide was mutated to CG was not active in transfected cells. These data suggest that the TTTAAA sequence functions as an atypical TATA box.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940071     DOI: 10.1074/jbc.271.48.30870

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Characterization of the alpha1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle.

Authors:  A D Eckhart; N Yang; X Xin; J E Faber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis.

Authors:  Claire R Weston; Anthony Wong; J Perry Hall; Mary E P Goad; Richard A Flavell; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

3.  Association between EGF promoter polymorphisms and cancer risk: a meta-analysis.

Authors:  Wei Xu; Yan Li; Xueli Wang; Bo Chen; Shan Liu; Yan Wang; Weihong Zhao; Jianqing Wu
Journal:  Med Oncol       Date:  2009-12-24       Impact factor: 3.064

4.  Functional epidermal growth factor gene polymorphisms and risk of gastric cancer.

Authors:  Zhen Zhan; Yajun Chen; Juan Wu; Junfeng Zhang; Shujuan Tong; Chunbing Zhang; Yaping Yang
Journal:  Oncol Lett       Date:  2012-11-22       Impact factor: 2.967

5.  Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population.

Authors:  Byeong Woo Kim; Su Kang Kim; Kyung Wook Heo; Ki Beom Bae; Kyung Hwan Jeong; Sang Ho Lee; Tae Hee Kim; Yeong Hoon Kim; Sun Woo Kang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.